UBS Group’s CryoPort CYRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-36,700
Closed -$568K 9417
2023
Q4
$568K Hold
36,700
﹤0.01% 5006
2023
Q3
$503K Buy
+36,700
New +$540K ﹤0.01% 4648
2023
Q1
Sell
-18,400
Closed -$319K 9710
2022
Q4
$319K Hold
18,400
﹤0.01% 5063
2022
Q3
$448K Sell
18,400
-65,000
-78% -$2.24M ﹤0.01% 4435
2022
Q2
$2.58M Buy
+83,400
New +$2.22M ﹤0.01% 2924

Other funds holding CYRX

UBS Group's CYRX Position: Q2 2026 in Review

UBS Group reduced its CryoPort (CYRX) stake by 6.9% in Q2 2026, selling an estimated $828K and leaving 868,266 shares worth $13.6M. The position accounts for ﹤0.01% of the portfolio, ranked #3094.

UBS Group first reported a position in CYRX in Q3 2015 and has held it in 39 quarters since. The position peaked at $13.7M in Q4 2025. 184 funds tracked by Wall St. Rank hold CYRX as of Q2 2026.

  • UBS Group held 868,266 shares of CryoPort worth $13.6M as of Q2 2026.
  • UBS Group sold 64,516 CryoPort shares in Q2 2026, an estimated $828K.
  • CryoPort made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #3094 holding.
  • UBS Group first reported a position in CryoPort in Q3 2015 and has held it in 39 quarters since.
  • UBS Group's CryoPort position peaked at $13.7M in Q4 2025.
  • 184 funds tracked by Wall St. Rank held CryoPort as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.